CT-Management of the investigational medicinal product (IMP) in the recruitment and delivery phase

[HMG1] Receipt, labelling, accountability etc of IMP should be managed, see CT SOP Investigational Medicinal Product Management during Trial. Before trial database lock, IMP should be accounted for, see CT SOP Investigational Medicinal Product Management at Trial Completion. When IMP is not a shelf product, there should be IMP reconciliation and destruction should be documented.

IMP Reconciliation

IMP Destruction